Status:
ACTIVE_NOT_RECRUITING
Observance of Continuous Positive Pressure for the Treatment of Obstructive Sleep Apnea Syndrome
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Obstructive Sleep Apnea Syndrome
Continuous Positive Airway Pressure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Moderate to severe obstructive sleep apnea syndrome (OSAS) (HAI hypopnea apnea index ≥ 15) is a common pathology, which affects 6 to 17% of the general population. The Alaska study, which involved 480...
Eligibility Criteria
Inclusion
- Adult patient (≥ 18 years old)
- Diagnosis of moderate to severe obstructive sleep apnea syndrome OSAS (AHI ≥ 15) by polygraphy or polysomnography performed in our Sleep disorder Unit
- Requiring CPAP therapy
- Informed consent
Exclusion
- Patient previously treated with CPAP therapy
- Psychiatric illness destabilized
- Unstable medical condition (i.e. COPD exacerbation, acute cardiac dysfunction, etc.)
- Planned obesity or ENT surgery (because CPAP treatment is planned for a short period)
- Central or mixed apnea syndrome
- Patient under 18 years old
- Pregnant, parturient or breastfeeding woman
- Patient under guardianship, curators or deprived of liberty
- Patient participating in another research including an exclusion period still in progress at the pre-inclusion.
Key Trial Info
Start Date :
May 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2026
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT05369845
Start Date
May 5 2022
End Date
June 1 2026
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France